What does VEGFR-2 stand for?

Vascular Endothelial Growth Factor Receptor-2

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Vascular Epidermal Growth Factor Vasoactive Endothelial Growth Factor vascular endothelial growth factor isoform consisting of 165 amino acids Vascular Endothelial Cell Growth Factor-A Vascular Endothelial Growth Factor Vascular Endothelial Growth Factor Neutralizing Antibody Vascular Endothelial Growth Factor B Vascular Endothelial Growth Factor C (protein) Vascular Endothelial Growth Factor D Vascular Endothelial Growth Factor Receptor		vascular endothelial growth factor C/D receptor Vascular Endothelial Growth Factor Receptor 1 Vascular Endothelial Growth Factor Receptor 2 Vascular Endothelial Growth Inhibitor Vermont Employment Growth Incentive (Vermont Department of Economic Development) Von Ebner Gland Protein Volle Evangelie Gemeente Rijswijk (Dutch: Rijswijk Full Gospel Church; Netherlands) Vancouver Eastside Girls Soccer Association (Canada) Vascular Endothelial Hyperplasia Vectored Exception Handler

Samples in periodicals archive:

The studies provide additional evidence that CYC116 inhibits Aurora kinases and Vascular Endothelial Growth Factor Receptor-2 tyrosine kinase or VEGFR-2 kinase.

Cyclacel Pharmaceuticals Presents Insights into the Mechanisms of Its ...

NEW YORK -- ImClone Systems Incorporated (NASDAQ: IMCL) today announced the commencement of patient treatment in a Phase I clinical trial of its fully human monoclonal antibody targeting the vascular endothelial growth factor receptor-2 (VEGFR-2), IMC-1121B, in patients with solid tumors.

ImClone Systems Commences Patient Treatment in U.S. Phase I Clinical ...

IMC-1121B is a fully human monoclonal antibody that is designed to bind to the vascular endothelial growth factor receptor-2 (VEGFR-2 or KDR) found on tumor vasculature, thereby inhibiting certain ligands known as vascular endothelial growth factors from binding to and activating the receptor.

ImClone Systems Receives U.S. Patent Covering Therapeutic ...